;
Author Verified
RCT
Published: Jul 2016
ACE Report #9177
Ace Report Cover Metabolic Disorders

Combination therapy improves site-specific BMD vs. teriparatide & denosumab monotherapies


Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Response to Therapy With Teriparatide, Denosumab, or Both in Postmenopausal Women in the DATA (Denosumab and Teriparatide Administration) Study Randomized Controlled Trial

J Clin Densitom. 2016 Jul-Sep;19(3):346-51

Contributing Authors: JN Tsai AV Uihlein SA Burnett-Bowie RM Neer BZ Leder PM Wallace

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.